Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites

British Journal of Cancer

Volumn 75, Issue 10, 1997, Pages 1519-1524

  Tsuda, H ^a   Sakamaki, C ^a   Fukutomi, T ^a   Hirohashi, S ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Human breast cancer; Involucrin; Recurrence; Squamoid features

Indexed keywords

ESTROGEN RECEPTOR; INVOLUCRIN;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CELL DEATH; CELL DIFFERENTIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL;

EID: 0030953621     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.260     Document Type: Article

References (23)

1. Blomm HJG and Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377
2. Bouizar Z, Spyratos F, Deytieux S, De Vernejoul M-C and Jullienne A (1993) Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res 53: 5076-5078
3. Carter D and Eggleston JC (1980) Tumors of the Lower Respiratory Tract. Atlas of Tumor Pathology, Second Series Fascicle 17. pp. 64-66. Armed Forces Institute of Pathology: Washington DC
4. Elston CW (1987) Grading of invasive carcinoma of the breast. In Diagnostic Histopathology of the Breast. Page DL and Anderson TV (eds). pp. 300-311. Churchill Livingstone: New York
5. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC and Cooperating Investigators (1975) The pathology of invasive breast cancer. A syllabus derived from findings of the national surgical adjuvant breast project (protocol no. 4). Cancer 36: 1-85
6. Hsu S-M, Raine M and Fanger H (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580
7. Kamby C, Anderson J, Ejlertsen B, Birkler NE, Rytter L, Zedeler K, Thorpe SM, Norgaard T and Rose C (1988) Histological grade and steroid receptor content of primary breast cancer - impact on prognosis and possible modes of action. Br J Cancer 58: 480-486
8. Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
9. Lipponen P, Aaltomaa S, Kosma VM and Syrjanen K (1994) Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30A: 2068-2073
10. Lynley AM and Dale BA (1983) The characterization of human epidermal filaggrin, a histidine-rich keratin filament-aggregating protein. Biochim Biophys Acta 744: 28-35
11. Majno G and Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15
12. Mehrel T, Hohl D, Rothnagel JA, Longley MA, Bundman D, Cheng C, Lichti U, Bisher ME, Steven AC, Steinert PM, Yuspa SH and Roop DR (1990) Identification of a major keratinocyte cell envelope protein, loricrin. Cell 61: 1103-1112
13. Murphy GF, Flynn TC, Rice RH and Pinkus GS (1984) Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J Invest Dermatol 82: 453-457
14. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J and Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1-39
15. Rice RH and Green H (1979) Presence in human epithelial cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18: 681-694
16. Said JW, Nash G, Sassoon AF, Shintaku P and Banks-Schlegel S (1983) Involucrin in lung tumors. A specific marker for squamous differentiation. Lab Invest 49: 563-568
17. Scarff RW and Torloni H (1968) Histological Typing of Breast Tumours. International Histological Classification of Tumours No. 2. pp. 17-18. World Health Organization: Geneva
18. Schmid C, Zatloukal K, Beham A and Denk H (1993) Involucrin expression in breast carcinomas: an immunohistochemical study. Vir Arch A Pathol Anat 423: 161-167
19. Silverberg SG and Kurman RJ (1992) Tumors of the Uterine Corpus and Gestational Trophoblastic Disease Atlas of Tumor Pathology. Third Series, Fascicle 3. pp. 54-62. Armed Forces Institute of Pathology: Washington DC
20. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Watanabe S, Terada M and Yamamoto H (1990a) Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma. A retrospective analysis of 176 cases. Cancer 65: 1794-1800
21. Tsuda H, Hirohashi S, Shimasato Y, Tanaka Y, Hirota T, Tsugane S, Shiraishi M, Toyoshima K, Yamamoto T, Terada M and Sugimura T (1990b) Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients. Jpn J Cancer Res 81: 327-332
22. Warhol MJ, Antonioni DA, Pinkus GS, Burke L, and Rice RH (1982) Immunoperoxidase staining for involucrin: a potential diagnostic aid in cervicovaginal pathology. Hum Pathol 13: 1095-1099
23. Watt FM and Green H (1981) Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol 90: 738-742